Effects of oral acrylamide intake on blood viscosity parameters in rats

Clinical Hemorheology and Microcirculation

Volumn 47, Issue 1, 2011, Pages 45-52

  Arihan, Okan ^a   Seringeç, Nurten B ^a   Gürel, Esin Leri ^a   Dikmenogronlu, Neslihan H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acrylamide; blood viscosity; erythrocyte deformability; hemorheology

Indexed keywords

ACRYLAMIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VISCOSITY; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMATOCRIT; MALE; NEUROTOXICITY; NONHUMAN; PLASMA VISCOSITY; RAT; VISCOMETER;

ACRYLAMIDE; ANIMALS; BLOOD VISCOSITY; CARCINOGENS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMATOCRIT; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79951818145     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1364     Document Type: Article

References (48)

1. L. Abramsson-Zetterberg, A.C. Vikström, M. Törnqvist and K.E. Hellenas, Differences in the frequency of micronucleated erythrocytes in humans in relation to consumption of fried carbohydrate-rich food, Mutation Res 653 (2008), 50-56.
2. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, M.R. Hardeman, F. Jung, H.J. Meiselman, G. Nash, N. Nemeth, B. Neu, B. Sandhagen, S. Shin, G. Thurston and J.L. Wautier, International expert panel for standardization of hemorheological methods: New guidelines for hemorheological methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
3. E. Bergmark, C.J. Calleman and L.G. Costa, Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat, Toxicol Appl Pharmacol 111 (1991), 352-363.
4. M. Bláha, E. Rencová, V. Bláha, R. Maĺy, M. Blazek, J. Studnicka, C. Andŕys, I. Fátorová, S. Filip, M. Kasparová, R. Procházková, J. Maĺy, R. Zimová and H. Langrová, The importance of rheological parameters in the therapy of microcirculatory disorders, Clin Hemorheol Microcirc 42 (2009), 37-46.
5. R.J. Bull, M. Robinson, R.D. Laurie, G.D. Stoner, E. Greisiger, J.R. Meieri and J. Stober, Carcinogenic effects of acrylamide in Sencar and A/J mice, Cancer Res 44 (1984), 107-111. (Pubitemid 14178069)
6. B. Catalgol, G. Ozhan and B. Alpertunga, Acrylamide-induced oxidative stress in human erythrocytes, Hum Exp Toxicol 28 (2009), 611-617.
7. Center for Evaluation of Risks to human Reproduction (CERHR). NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Acrylamide. National Toxicology Program, U.S.DHHS. NIH Publication No. 05 (2004), 4472. Available at: http://cerhr.niels.gov/chemicals/acrylamide/ Acrylamide Monographs.pdf (Accessed October, 2008).
8. F.C. Clement, R. Dip and H. Naegeli, Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heat-induced food carcinogen acrylamide, Toxicology 240 (2007), 111-124. (Pubitemid 47445964)
9. Cosmetic Ingredient Review, Final report on the safety assessment of polyacrylamide, J Am Coll Toxicol 10 (1991), 193-203.
10. S. de Oliveira and C. Saldanha, An overview about erythrocyte membrane, Clin Hemorheol Microcirc 44 (2010), 63-47.
11. European Union (EU), Existing Chemicals Branch. Risk Assessment of Acrylamide, Luxenbourg: Office for Official Publications of the European Communities, 2000.
12. T.R. Fennell, S.C. Sumner, R.W. Snyder, J. Burgess, R. Spicer, W.E. Bridson and M.A. Friedman, Metabolism and hemoglobin adduct formation of acrylamide in humans, Toxicol Sci 85 (2005), 447-459. (Pubitemid 40614275)
13. M.A. Friedman, L. Dulak and M.A. Stedham, A lifetime oncogenicity study in rats with acrylamide, Fundam Appl Toxicol 25 (1995), 95-105.
14. M.R. Hardeman, P.T. Goedhart, J.G.G. Dobbe and K.P. Lettinga, Laser assisted optical rotational cell analyzer (L.O.R.C.A). I. A new instrument for measurement of various structural hemorheological parameters, Clin Hemorheol 14 (1994), 605-618. (Pubitemid 24239378)
15. M.R. Hardeman, J.G.G. Dobbe and C. Ince, The laser-assisted optical rotational cell analyzer (LORCA) as red blood cell aggregometer, Clin Hemorheol Microcirc 25 (2001), 1-11. (Pubitemid 34014671)
16. S.K. Jain, N. Mohandas, M.R. Clark and S.B. Shohet, The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration and 51Cr-survival of erythrocytes, Br J Haematol 53 (1983), 247-255. (Pubitemid 13171498)
17. G.J. Jenkins, S.H. Doak, G.E. Johnson, E. Quick, E.M. Waters and J.M. Parry, Do dose response thresholds exist for genotoxic alkylating agents, Mutagenesis 20 (2005), 389-398. (Pubitemid 41816525)
18. E. Kahana, J.C. Pinder, K.S. Smith and W.B. Gratzer, Fluorescence quenching of spectrin and other red cell membrane cytoskeletal proteins, Biochem J 282 (1992), 75-80.
19. A.J. Lee, P.I. Mowbray, G.D.O. Lowe, A. Rumley, G.R. Fowkes and P.L. Allan, Blood viscosity and elevated carotid intima-media thickness in men and woman, Circulation 97 (1998), 1467-1473. (Pubitemid 28191302)
20. G.D.O. Lowe, A.J. Lee, J.F. Price and F.G.R. Fowkes, Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study, Brit J Haematology 96 (1997), 168-173.
21. G.D.O. Lowe, M.M. Drummond, A.R. Lorimer, I. Hutton, C.D. Forbes, C.R.M. Prentice and J.C. Barbenel, Relation between extent of coronary artery disease and blood viscosity, British Medical Journal 280 (1980), 673-674. (Pubitemid 10184295)
22. G.D.O. Lowe, T.C. Pearson, J. Stuart, D.J. Thomas and C.H.M. Walker, Clinical Blood Rheology, CRC Press, Boca Raton-Florida 1 (1998), 1-85.
23. G. Lowe, A. Rumley, J. Norrie, I. Ford, J. Shepherd, S. Cobbe, P. Macfarlane and C. Packard, Blood rheology, cardiovascular risk factors and cardiovascular disease: The west of Scotland coronary prevention study, Thromb Haemost 84 (2000), 553-558.
24. A. Marossy, P. Svorc, I. Kron and S. Gresová, Hemorheology and circulation, Clin Hemorheol Microcirc 42 (2009), 239-258.
25. J. McKenney, C.R. Valeri, N. Mohandas, N. Fortier, A. Giorgio and L.M. Snyder, Decreased in vivo survival of hydrogen peroxide-damaged baboon red blood cells, Blood 76 (1990), 206-211. (Pubitemid 20220812)
26. National Toxicology Program (NTP), 11th Report on Carcinogens. National Toxicology Program, DHHS, III-4, Research Triangle Park, N.C., 2004.
27. C. Pfafferott, H.J. Meiselman and P. Hochstein, The effect of malonyldialdehyde on erythrocyte deformability, Blood 59 (1982), 12-15. (Pubitemid 12162339)
28. R. Schlegel and J.T. MacGregor, The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fischer 344 rats: Implications for cytogenetic screening, Mutat Res 127 (1984), 169-174. (Pubitemid 14089639)
29. D. Sharp, Acrylamide in food, Lancet 361 (2003), 362.
30. A. Shipp, G. Lawrence, R. Gentry, T. McDonald, H. Bartow, J. Bounds, N. Macdonald, H. Clewell, B. Allen and C. Van Landingham, Acrylamide: Rewiev of toxicity data and dose-response analyses for cancer and noncancer effects, Crit Rev Toxicol 36 (2006), 481-608. (Pubitemid 44396721)
31. D.W. Sickles, A.O. Sperry, A. Testino and M. Friedman, Acrylamide effects on kinesin-related proteins of the mitotic/ meiotic spindle, Toxicol Appl Pharmacol 222 (2007), 111-121. (Pubitemid 46962661)
32. M. Simo, M. Santaolaria, J. Murado, M.L. Perez, D. Corella and A. Vaya, Erythrocyte deformability in anaemic patiens with reticulocytosis determined by means of ektacytometry techniques, Clin Hemorheol Microcirc 37 (2007), 263-267. (Pubitemid 350032252)
33. E.A. Smith and F.W. Oehme, Acrylamide and polyacrylamide: A review of production, use environmental fate and neurotoxicity, Rev Environ Health 9 (1991), 215-228.
34. L.M. Snyder, N.L. Fortier, J. Trainor, J. Jacobs, L. Leb, B. Lubin, D. Chiu, S. Shohet and N. Mohandas, Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrinhemoglobin cross-linking, J Clin Invest 76 (1985), 1971-1977. (Pubitemid 16196072)
35. P.S. Spencer and H. Schaumburg, A review of acrylamide neurotoxicity. Part I. Properties, use and human exposure, Can J Neurol Sci 1 (1974), 143-150.
36. M.A. Srour, Y.Y. Bilto, M. Juma and M.R. Irhimeh, Exposure of human erythrocytes to oxygen radicals causes loss of deformability, increased osmotic fragility, lipid peroxidation and protein degradation, Clin Hemorheol Microcir 23 (2000), 13-21. (Pubitemid 32047488)
37. S.C. Sumner, J.P. MacNeela and T.R. Fennell, Characterization and quantification of urinary metabolites of[1,2,3-13C)] acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy, Chem Res Toxicol 5 (1992), 81-89.
38. K. Svensson, L. Abramsson, W. Becker, A. Glynn, K.E. Hellenas, Y. Lind and J. Rosen, Dietary intake of acrylamide in Sweden, Food Chem Toxicol 41 (2003), 1581-1586. (Pubitemid 37088113)
39. E. Tareke, P. Rydberg, P. Karlsson, S. Eriksson and M. Tornquist, Acrylamide: A cooking carcinogen, Chem Res Toxicol 13 (2000), 517-522.
40. E. Tareke, P. Rydberg, P. Karlsson, S. Eriksson and M. Tornquist, Analysis of acrylamide, a carcinogen formed in heated foodstuffs, J Agric Food Chem 50 (2002), 4998-5006. (Pubitemid 34856181)
41. M.M. Tarskikh, Damage to erythrocyte membranes as the mechanism for acrylate toxicity, Bulletin of Experimental Biology and Medicine 142 (2006), 6.
42. U.S. EPA. Assessment of Health Risks from Exposure to Acrylamide; Office of Toxic Substances, U.S. Environmental Protection Agency: Washington, DC, 1990.
43. U.S. EPAPeer Review, Draft of Toxicological Reviewof Acrylamide. Integrated Risk Information System, National Center for Environmental Assessment. Office of Research and Development. U.S. Environmental Protection Agency,Washington DC, 2007. Available at: http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid=187729. 418811.
44. N. Uyesaka, S. Hasegawa, N. Ishioka, R. Ishioka, H. Shio and A.N. Schechter, Effects of superoxide anions on red cell deformability and membrane proteins, Biorheology 29 (1992), 217-229.
45. C. Van Landingham, G. Lawrence and A. Shipp, Estimates of lifetime-absorbed daily doses from the use of personal-care products containing polyacrylamide: A monte carlo analysis, Risk Anal 24 (2004), 603-619. (Pubitemid 38864752)
46. L.S. Von Tungeln, M.I. Chruchwell, D.R. Doerge, J.G. Shaddock, L.J. McGarrity, R.H. Heflich, G.C. da Costa, M.M. Marques and F.A. Beland, DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide, Int J Cancer 124 (2009), 2006-2015.
47. K.L.Witt, E. Livanos, G.E. Kissling, D.K. Torous,W. Caspary, R.R. Tice and L. Recio, Comparison of flow ctyometry- and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic chemicals, Mutat Res 649 (2008), 101-113. (Pubitemid 350235297)
48. E. Zeiger, L. Recio, T.R. Fennell, J.K. Haseman, R.W. Snyder and M. Friedman, Investigation of low-dose response in the in vivo induction of micronuclei and adducts by acrylamide, Toxicological Sciences 107 (2009), 247-257.